Dorzagliatin
Dorzagliatin is a glucokinase activator made to treat diabetes.[1] Unlike other drugs, it works to increase the insulin sensitivity.[2]
References
- ↑ Chow, Elaine. Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes. Diabetes 72 (2) (1 February 2023). p. 299–308. doi:10.2337/db22-0708.
- ↑ Zhu, Dalong. Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial. Nature Medicine 28 (5) (May 2022). p. 965–973.
